Tor Audun Hervig (Tor A Hervig, Tor Hervig, T Hervig)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

Induced Apoptosis

Quality Improvement

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Joar Sivertsen, Tor Audun Hervig, Geir Strandenes, Einar K Kristoffersen, Hanne Braathen, Torunn Oveland Apelseth
In vitro quality and hemostatic function of cold-stored CPDA-1 whole blood after repeated transient exposure to 28°C storage temperature. Transfusion (2022)
Turid Helen Felli Lunde, Lindsay Hartson, Shawn Lawrence Bailey, Tor Audun Hervig
In vitro characteristics and in vivo platelet quality of whole blood treated with riboflavin and UVA/UVB light and stored for 24 hours at room temperature. Transfusion (2021)
Daniel Cacic, Håkon Reikvam, Oddmund Nordgård, Peter Meyer, Tor Audun Hervig
Platelet Microparticles Protect Acute Myelogenous Leukemia Cells against Daunorubicin-Induced Apoptosis. Cancers 13 (8) (2021)
Tor Audun Hervig, Heidi A Doughty, Rebecca A Cardigan, Torunn O Apelseth, John R Hess, Femke Noorman, Miloš Bohoněk, Mark H Yazer, Jia Lu, Silvano Wendel, Rosemary L Sparrow, null null
Re-introducing whole blood for transfusion: considerations for blood providers. Vox sanguinis 116 (2) (2020)
Pieter F van der Meer, Paula F Ypma, Anna A van Geloven, Joost A van Hilten, Rinie J van Wordragen-Vlaswinkel, Okke Eissen, Jaap Jan Zwaginga, Michael Trus, Erik A M Beckers, Peter A W Te Boekhorst, Alan Tinmouth, Yulia Lin, Cyrus C Hsia, David Lee, Phillip J Norris, Raymond P Goodrich, Anneke Brand, Tor Audun Hervig, Nancy M Heddle, Johanna van der Bom, Jean-Louis H Kerkhoffs
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial. Blood 132 (2) (2018)
E N Opheim, T O Apelseth, S J Stanworth, G E Eide, Tor Audun Hervig
Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients. Vox sanguinis 112 (6) (2017)